Navigation Links
Nearly 18 Million Will Have Macular Degeneration by 2050

But newer treatments could reduce related blindness by almost 35%, study suggests,,,,

TUESDAY, April 14 (HealthDay News) -- Although the rate of age-related macular degeneration is on the increase, newer treatments could help reduce the most serious effects of the disease by about 35 percent, new estimates suggest.

In a study funded by the U.S. Centers for Disease Control and Prevention, researchers report that as many as 9.1 million people will have age-related macular degeneration (AMD) in 2010, but that 17.8 million people will have the potentially blinding eye disease by 2050.

"What we found is that due to aging, the number of cases of early and advanced AMD will increase dramatically no matter what," said study author David Rein, a senior research economist from RTI International in Research Triangle Park, N.C. "In 2050, we project there will be 1.57 million cases of blindness [caused by AMD] with no treatment. But, with vigorous treatment, that number's just about 1 million."

Results of the study are published in the April issue of the Archives of Ophthalmology.

Age-related macular degeneration is a serious eye disease that causes the breakdown of the macula, which is located in the retina. The macula gives you clear central vision, which is essential for reading and driving, even for just seeing people's faces. AMD is a leading cause of vision loss in people over 65, according to the American Academy of Ophthalmologists (AAO).

Risk factors for AMD include advancing age, a family history of the disease, high blood pressure, smoking and obesity, according to the AAO. Though there are treatments that help some people, there is no cure for AMD.

Most of the treatments for AMD are relatively new, only widely available since about 2001, according to Rein. The easiest and cheapest intervention is a special vitamin/mineral combination (vitamins C, E, beta carotene, zinc and copper) that may slow the progression of AMD. This treatment only costs about $100 per year, and when used early in the disease can "reduce vision-threatening disease by 25 percent," Rein noted.

Other possible treatments include anti-vascular endothelial growth factor (anti-VEGF), which slows the growth of leaking blood vessels in the eyes, laser therapy or photodynamic therapy (PDT), which combines the use of medication and laser therapy to reduce blood vessel leakage in the eyes.

Using a statistical model, the researchers estimated that the rate of visual impairment would drop by 2.4 percent if everyone with AMD were treated with PDT alone, but by 22 percent if PDT was combined with vitamin treatments. If, in the future, everyone were treated with laser therapy and anti-VEGF, visual impairment and blindness from AMD would decrease by 16.9 percent, and the final scenario -- early vitamin treatment and laser therapy -- would reduce serious visual problems in AMD by 34.5 percent.

"Age-related macular degeneration is a major public health problem, and as people are living longer, more people are going to develop some form of macular degeneration," said Dr. Alexander Aizman, a clinical instructor in the department of ophthalmology at New York University School of Medicine in New York City. "The scenarios in this study are very plausible."

Aizman said that although there's currently no specific preventive treatment to avoid AMD altogether, the same things that keep your heart and the rest of your body healthy -- maintaining the proper weight, exercising, not smoking and avoiding secondhand smoke -- can also help keep your eyes healthy.

"If you have a relative who has been diagnosed with AMD, it's important to know that you're probably at a higher risk of AMD than the general population," said Aizman. "If you're 60 or older, have regular eye checkups with an ophthalmologist or a retinal specialist to find out if you have any early changes that suggest AMD."

More information

Learn more about age-related macular degeneration from the National Eye Institute.

SOURCES: David Rein, Ph.D., senior research economist, RTI International, Research Triangle Park, N.C.; Alexander Aizman, M.D., clinical instructor, department of ophthalmology, New York University School of Medicine, New York City; April 2009, Archives of Ophthalmology

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. National Physicians Study: Nearly One Third Would Choose Different Career Today
2. 70% of Contact Lens Cases are Contaminated and Nearly 1 in 4 are Never Replaced - a Serious Problem Eye Doctors Want Fixed, WatchDog Group Reports
3. Human Services, Health Organizations and Transit Receive a Majority of Kresges Nearly $73 Million in First Quarter Grants
4. Nearly 900 Workers at Caritas St. Elizabeths Medical Center Make History With Vote to Join 1199SEIU
5. Survey Shows Nearly 40 Percent of Americans Reel From Heel Pain
6. Consumer Reports Poll: Nearly 3 in 10 Hispanics Opted Not to Fill M.D. Script for Cost Reasons
7. US Spinal Nonfusion Procedures Set to Increase Nearly Five Times From 2008 to 2013, According to Millennium Research Group
8. Case Western Reserve awarded nearly $1 million from Research to Prevent Blindness Foundation
9. Nearly 1.4 Million Sustain Traumatic Brain Injuries Each Year
10. Give Kids A Smile Provides Free Oral Health Care to Nearly Half-Million Children
11. 17th Annual Elton John AIDS Foundation Party Celebrating the Academy Awards Raises Nearly $4 Million
Post Your Comments:
Related Image:
Nearly 18 Million Will Have Macular Degeneration by 2050
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: